Retinopathy Clinical Trials in Palo Alto, California
6 recruitingPalo Alto, California
Showing 1–6 of 6 trials
Recruiting
Phase 2
Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation
Normal Tension Glaucoma (NTG)Non-proliferative Diabetic Retinopathy (NPDR)Open-angle Glaucoma (OAG)
Qlaris Bio, Inc.14 enrolled1 locationNCT07354477
Recruiting
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Blood PressureNeuropathyDiabetes+6 more
Jaeb Center for Health Research200 enrolled18 locationsNCT06837181
Recruiting
Phase 2
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
Diabetic Retinopathy
Boehringer Ingelheim178 enrolled89 locationsNCT06321302
Recruiting
Phase 3
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
Visual ImpairmentRadiation Retinopathy
Jaeb Center for Health Research600 enrolled22 locationsNCT05844982
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
Diabetic RetinopathyNPDR - Non Proliferative Diabetic Retinopathy
Vantage Biosciences Ltd100 enrolled26 locationsNCT06770933
Recruiting
Clinical and Genetic Analysis of ROP
Retinopathy of Prematurity
Oregon Health and Science University2,000 enrolled5 locationsNCT04420156